Clinical Evidence
About Our Research
The First Cleared by the FDA
The Anodyne Therapy System was the first product that used light for pain relief that the FDA believed worthy to clear for human use in 1994. Anodyne continues its market leadership in evidence-based light therapy products.
Anodyne is Proven
25 studies published in noted medical journals prove the pain relieving benefits of the Anodyne Therapy Systems. These studies used Anodyne products not some other device. Anodyne studies are published in such recognized medical journals as Diabetes Care, Practical Pain Management, Age and Ageing, and Endocrine Practice.
Don't Be Fooled
All light therapy products are not alike even if they have all been cleared by the FDA. Unlike Anodyne, most light therapy products have no published evidence that they work. They rely solely on testimonials, general scientific evidence related to light therapy in general or studies conducted with other peoples’ products.
Anodyne Therapy is MIRE
Throughout our studies, the acronym MIRE is referenced. MIRE is Monochromatic Infrared Energy and is a trademark of Anodyne Therapy technology specifically.
Published Clinical Data
Foot Pain Studies
The authors of the following published studies describe pain relief obtained by over 4,000 patients who received treatment with the Anodyne Therapy System.
Monochromatic Infrared Photo Energy in Diabetic Peripheral Neuropathy
Patients treated with Anodyne Therapy obtained more pain relief than those who were not treated with Anodyne.
read more...Infrared Photo Energy May Reduce Neuropathic Pain
Patients who received Anodyne Therapy treatments experienced a 64% reduction in pain.
read more...Improved Foot Sensitivity and Pain Reduction in Patients with Peripheral Neuropathy After Treatment with Monochromatic Infrared Photo Energy—MIRE
Pain/discomforting foot sensations decreased by 67%.
read more...Effectiveness of Monochromatic Infrared Photo Energy and PT for Peripheral Neuropathy
More than 90% of patients obtained significant foot pain relief.
read more...Symptomatic Reversal of Peripheral Neuropathy in Patients with Diabetes
94% of patients reported significant relief from their pain/discomforting foot sensations.
read more...Improvement of Sensory Impairment in Patients with Peripheral Neuropathy
96% of patients obtained relief from pain/discomforting foot sensations.
read more...Restoration of Sensation, Reduced Pain, and Improved Balance in Subjects With Diabetic Peripheral Neuropathy
Patients obtained significant pain relief after both 2 and 4 weeks of treatment.
read more...Monochromatic Infrared Photo Energy and Physical Therapy for Peripheral Neuropathy: Influence on Sensation, Balance and Falls
90% relief of discomforting foot symptoms.
read more...Improved Sensitivity in Patients with Peripheral Neuropathy Effects of Monochromatic Infrared Photo Energy
88% relief from pain/discomforting foot sensations.
read more...Reversal of Diabetic Peripheral Neuropathy with MIRE
87% of patients reported continuing foot pain relief after 9 months!
read more...A Combined Treatment Protocol for Patients With Diabetic Peripheral Neuropathy
Following completion of the clinic-based protocol, the study evaluated the real-life results of ongoing unsupervised home use of Anodyne Therapy.
read more...The Efficacy of Monochromatic Infrared Photo-Thermal Energy Therapy in Rehabilitation: A Pilot Study report
Patients receiving treatments with Anodyne Therapy showed significant pain relief, improved feeling, and better balance.
read more...Near-Infrared Photo Energy Therapy (Anodyne) could Reduce Diabetic Peripheral Neuropathic Pain
More than 88% of patients receiving treatments with Anodyne Therapy and physical therapy obtained significant pain relief and used less pain relieving pain medications.
read more...Knee & Back Pain Studies
The authors of the following published studies describe pain relief obtained with the Anodyne Therapy System compared to conventional treatments.
Monochromatic Infrared Photo Energy in Patients with Knee Osteoarthritis
57% reduction in their knee pain.
read more...Monochromatic Infrared Photo Energy versus Low Level Laser Therapy in Patients with Knee Osteoarthritis
51% decrease in knee pain.
read more...Short-term therapeutic effects of 890-nanometer light therapy for chronic low back pain: a double-blind randomized placebo-controlled study
Reduced severity of disability.
read more...Monochromatic Infrared Photo Energy Versus Low Level Laser Therapy in Chronic Low Back Pain
Patients receiving treatments with Anodyne Therapy showed significant back pain relief, decreased disability, and improved pain free low back range of motion.
read more...About Our Clinical Evidence
These summaries are intended to fairly summarize the results in published studies. However, we suggest a review of the entire published studies to reach an independent understanding of the reported results and study limitations.
Individual response may differ from those reported in these published studies.
Anodyne is Anodyne Therapy, which is cleared by the FDA for the relief of pain, increase in circulation and reduction of muscle spasm. Our company, Anodyne Therapy, LLC only states that there is change in painful and discomforting symptoms in response to treatment; it does not make any additional marketing claims nor does it make any claim that Anodyne Therapy treats or cures the underlying diagnosis potentially causative of painful symptoms.
